Radcliffe Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Radcliffe Capital Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-67,527	Closed	-$680K	–	847
2022 Q4	$680K	Hold	67,527	–	–	0.02%	750
2022 Q3	$669K	Buy	67,527 +55,644	+468%	+$548K	0.02%	1020
2022 Q2	$116K	Hold	11,883	–	–	﹤0.01%	1222
2022 Q1	$116K	Hold	11,883	–	–	﹤0.01%	1205
2021 Q4	$116K	Hold	11,883	–	–	﹤0.01%	1044
2021 Q3	$116K	Hold	11,883	–	–	﹤0.01%	892
2021 Q2	$115K	Buy	+11,883	New	+$116K	﹤0.01%	910

Radcliffe Capital Management's MSAC Position: Q1 2023 in Review

Radcliffe Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 67,527 shares — an estimated $680K sold.

Radcliffe Capital Management first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $680K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Radcliffe Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Radcliffe Capital Management sold 67,527 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $680K.
Radcliffe Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Radcliffe Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $680K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.